Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size study, by Product (Synthetic, Biotech), by Manufacturer (In-house, Outsourced), by Drug Type (Generic, Innovative), Therapeutic Application (Oncology, Hormonal, Glaucoma and Others) and Regional Forecasts 2021-2027

BIZ4457805
200 Pages
June 2021
Pharmaceuticals

Download Sample Get Discount

Global HPAPI Market is valued approximately USD 21.08 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.00% over the forecast period 2021-2027. Active pharmaceutical ingredient is a raw substance or mixture of substances used in the manufacturing of a medicinal drug. An API is classified as an HPAPI if it has an occupational exposure limit at or below 10 micrograms per cubic meter of air. They have the ability to target the diseased cells more precisely and selectively than other APIs and hence are very crucial in diseases such as cancer. The higher demand for HPAPIs in the treatment of cancer patients, increasing investments from private and government players and growing focus on precision treatment are the major drivers for HPAPI market. Above mentioned advantages, coupled with the new technological development in manufacturing of HPAPI, are propelling the growth of the HPAPI market. The APIs are the crucial part of pharmaceutical industry. The significantly high growth of the industry after the COVID-19 pandemic has increased the demand of APIs. There was a huge disruption in pharmaceutical supply chain during lockdowns in pandemic which resulted in scarcity of APIs worldwide. The various governments, including Indian and other Asian countries, are now trying to upgrade the manufacturing of APIs domestically to reduce the reliance on China. These efforts are also driving the growth of high potency active pharmaceutical ingredients market. In 2020, the government of India announced Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of APIS, in which financial incentive will be given to qualified manufacturers of known 41 eligible products which covers 53 APIs for next 6 years. Another scheme from government allocates INR 3000 Crores for providing financial assistance for construction of common infrastructure facilities in 3 bulk drug parks across various states. High potency APIs are toxic in nature and thus require high level of care in their disposal. The issue in the management, storage and associated regulations with APIs may act as a restraint for its growth. However, increasing cases of cancer and other diseases requiring HPAPIs act as an opportunity for HPAPI Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of HPAPI Market. Due to higher demand in oncology treatment as well as higher per capita income, North America emerged as a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing number of cancer patients and increasing expenditure on healthcare facilities.

Major market player included in this report are:

Eli Lilly and Company

Novartis AG

Bristol-Myers Squibb Company

Roche Diagnostics Ltd.

Sanofi

Hospira, Inc.

BASF SE

Covidien plc

Boehringer Ingelheim GmbH

Merck & Co., Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Synthetic

Biotech

By Manufacturer:

In-house

Outsourced

By Drug-Type:

Innovative

Generic

By Therapeutic:

Oncology

Hormonal

Glaucoma

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global HPAPI Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1.Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. HPAPI Market, by Product, 2019-2027 (USD Billion)

1.2.2. HPAPI Market, by Manufacturer, 2019-2027 (USD Billion)

1.2.3. HPAPI Market, by Drug Type, 2019-2027 (USD Billion)

1.2.4. HPAPI Market, by Therapeutic, 2019-2027 (USD Billion)

1.2.5. HPAPI Market, by, 2019-2027 (USD Billion)

1.2.6. HPAPI Market, by, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global HPAPI Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global HPAPI Market Dynamics

3.1. HPAPI Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increase demand from oncology patients

3.1.1.2. Rise in R&D expenditure in high potency APIs

3.1.2. Market Challenges

3.1.2.1. Handling and management of toxic HPAPIs

3.1.3. Market Opportunities

3.1.3.1. Rising cases of cancer-related diseases

Chapter 4. Global HPAPI Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global HPAPI Market, by Product

5.1. Market Snapshot

5.2. Global HPAPI Market by Product, Performance - Potential Analysis

5.3. Global HPAPI Market Estimates & Forecasts by Product 2018-2027 (USD Billion)

5.4. HPAPI Market, Sub Segment Analysis

5.4.1. Synthetic

5.4.2. Biotech

Chapter 6. Global HPAPI Market, by Manufacturer

6.1. Market Snapshot

6.2. Global HPAPI Market by Manufacturer, Performance - Potential Analysis

6.3. Global HPAPI Market Estimates & Forecasts by Manufacturer 2018-2027 (USD Billion)

6.4. HPAPI Market, Sub Segment Analysis

6.4.1. In-house

6.4.2. Outsourced

Chapter 7. Global HPAPI Market, by Drug Type

7.1. Market Snapshot

7.2. Global HPAPI Market by Drug Type, Performance - Potential Analysis

7.3. Global HPAPI Market Estimates & Forecasts by Drug Type 2018-2027 (USD Billion)

7.4. HPAPI Market, Sub Segment Analysis

7.4.1. Innovative

7.4.2. Generic

Chapter 8. Global HPAPI Market, by Therapeutic

8.1. Market Snapshot

8.2. Global HPAPI Market by Therapeutic, Performance - Potential Analysis

8.3. Global HPAPI Market Estimates & Forecasts by Therapeutic 2018-2027 (USD Billion)

8.4. HPAPI Market, Sub Segment Analysis

8.4.1. Oncology

8.4.2. Hormonal

8.4.3. Glaucoma

8.4.4. Others

Chapter 9. Global HPAPI Market, Regional Analysis

9.1. HPAPI Market, Regional Market Snapshot

9.2. North America HPAPI Market

9.2.1. U.S. HPAPI Market

9.2.1.1. Product breakdown estimates & forecasts, 2018-2027

9.2.1.2. Manufacturer breakdown estimates & forecasts, 2018-2027

9.2.1.3. Drug Type breakdown estimates & forecasts, 2018-2027

9.2.1.4. Therapeutic breakdown estimates & forecasts, 2018-2027

9.2.2. Canada HPAPI Market

9.3. Europe HPAPI Market Snapshot

9.3.1. U.K. HPAPI Market

9.3.2. Germany HPAPI Market

9.3.3. France HPAPI Market

9.3.4. Spain HPAPI Market

9.3.5. Italy HPAPI Market

9.3.6. Rest of Europe HPAPI Market

9.4. Asia-Pacific HPAPI Market Snapshot

9.4.1. China HPAPI Market

9.4.2. India HPAPI Market

9.4.3. Japan HPAPI Market

9.4.4. Australia HPAPI Market

9.4.5. South Korea HPAPI Market

9.4.6. Rest of Asia Pacific HPAPI Market

9.5. Latin America HPAPI Market Snapshot

9.5.1. Brazil HPAPI Market

9.5.2. Mexico HPAPI Market

9.6. Rest of The World HPAPI Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Eli Lilly and Company

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Novartis AG

10.2.3. Bristol-Myers Squibb Company

10.2.4. Roche Diagnostics Ltd.

10.2.5. Sanofi

10.2.6. Hospira, Inc.

10.2.7. BASF SE

10.2.8. Covidien plc

10.2.9. Boehringer Ingelheim GmbH

10.2.10. Merck & Co., Inc.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global HPAPI Market, report scope

TABLE 2. Global HPAPI Market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global HPAPI Market estimates & forecasts by Product 2018-2027 (USD Billion)

TABLE 4. Global HPAPI Market estimates & forecasts by Manufacturer 2018-2027 (USD Billion)

TABLE 5. Global HPAPI Market estimates & forecasts by Drug Type 2018-2027 (USD Billion)

TABLE 6. Global HPAPI Market estimates & forecasts by Therapeutic 2018-2027 (USD Billion)

TABLE 7. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. U.S. HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. U.S. HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 19. U.S. HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 20. Canada HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. Canada HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 22. Canada HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. UK HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 24. UK HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. UK HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Germany HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 27. Germany HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. Germany HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. RoE HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 30. RoE HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. RoE HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. China HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 33. China HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. China HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. India HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 36. India HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. India HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Japan HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 39. Japan HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. Japan HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. RoAPAC HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 42. RoAPAC HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. RoAPAC HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. Brazil HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 45. Brazil HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. Brazil HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. Mexico HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 48. Mexico HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. Mexico HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. RoLA HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 51. RoLA HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. RoLA HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Row HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 54. Row HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. Row HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. List of secondary sources, used in the study of global HPAPI Market

TABLE 57. List of primary sources, used in the study of global HPAPI Market

TABLE 58. Years considered for the study

TABLE 59. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size study, by Product (Synthetic, Biotech), by Manufacturer (In-house, Outsourced), by Drug Type (Generic, Innovative), Therapeutic Application (Oncology, Hormonal, Glaucoma and Others) and Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara